Thalidomide, the notorious drug which caused horrendous birth defects in the 1950s and 1960s, is close to making a comeback as an anticancer drug. Drug firm Celgene of Warren, New Jersey, has applied to European drug authorities for permission to sell thalidomide to treat multiple myeloma, a fatal cancer of the bone marrow. In clinical trials the drug performed well against the disease. It will take Europe seven months or more to reach a verdict on the drug, which will not be prescribed to pregnant women or those considering having children.
More from New Ä¢¹½Ö±²¥
Explore the latest news, articles and features
Technology
Laser weapons have come of age and are making their way to the battlefield
News
Society
Timeline: The biggest breakthroughs of the past 70 years
Features
Space
We now know how radiation destroys electronics devices
News
Society
“The gut microbiome will become part of every person’s medical record”
Features
Popular articles
Trending New Ä¢¹½Ö±²¥ articles